ATLANTA, Feb. 16, 2017 -- Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has entered into an agreement with MUCOM, L.L.C. to broker the sale or license of its patented male urinary incontinence device MUI Comfort™.
MUI Comfort™ is an integrated external collection system that meets the needs of a growing demographic that is coping with the consequences of stress, urge, and overflow incontinence. This innovative technology is differentiated from competing products by providing a complete solution that addresses both functional and psychological aspects associated with male urinary incontinence. MUI Comfort™ has several elements that are central to its patented design including:
- A lightweight collection bag with an integrated drainage neck and secured opening.
- A soft inner liner to protect the skin from perspiration and potential allergenic reaction.
- An enlarged opening with an adjustable closure mechanism that is part of three key elements that prevent accidental leaks, protect the skin, and provide secure fixation.
- A wicking component that draws urine into a superabsorbent-deodorizing polymer and will bond with any liquid to minimize odor, prevent sloshing and leakage.
- Watch the video
“We are excited to be working with the MUCOM team and representing such innovative technology that can provide millions of effected men with a superior management option for their stress, urge, and overflow incontinence,” commented Paul Gianneschi, Managing Principal at Hatch Medical L.L.C.
Donna Lou DuPree McCormack, RN, BSN, President of MUCOM, LLC commented, “We are excited to offer this innovative technology to countless men who are subjected to the embarrassment and social isolation of urinary incontinence, who have been underserved by disappointing products. Our patented technology has the potential to enhance the wellness and quality of life for untold millions of males as they eliminate the use of diapers and pads. We are delighted to be working with Hatch Medical to bring this new technology to the market.”
Founded in 2000, Hatch Medical is an incubator and broker of medical device technologies, assisting clients with development, licensing, distribution and asset sales. For information on this, or other Hatch Medical, L.L.C. products and services, email the company at [email protected]. This release and additional news about Hatch Medical can be obtained by visiting the company’s web site -- http://www.hatchmedical.com.
Contact Paul Gianneschi, Managing Principal, 770-476-9940, Steve Hvozda, Principal 949-388-9335, or Gary Robinson 215-353-0362


Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Chinese Cars in Europe: Consumer Trust Is Shifting Fast
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Bill Ackman Eyes New Fund to Bet Against Market Complacency 



